US FDA approves Bristol Myers’ oral heart disease drug
The company said the drug comes with a boxed warning for the risk of heart failure
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Bristol-Myers’
Nektar stops clinical trials for key cancer drug
The trials that Nektar stopped included those involving a combination of its drug Bempegaldesleukin with Bristol Myers Squibb Co’s…
US FDA approves new Bristol Myers cancer immunotherapy
The company said it expects the treatment to eventually garner annual sales of more than $4 billion
US FDA approves CTI BioPharma’s bone marrow cancer drug
The drug, Vonjo (pacritinib), belongs to a class of anti-inflammatory treatments called JAK inhibitors, and will compete with…
WuXi STA completes acquisition of Bristol Myers Squibb manufacturing facility in Switzerland
The facility enhances WuXi STA's drug product capacity in Europe while better enabling global customers
USFDA extends review of Bristol Myers’ cancer therapy acquired in Celgene deal
The company said it had submitted additional information on the therapy known as liso-cel, which was considered a major amendment…
Bluebird bio, Bristol-Myers’ multiple myeloma therapy shows promise in early study
The lowest dose of the therapy, bb21217, had a median duration of response of 11.1 months and an overall response rate of 83 per…